New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Urologix (ULGX)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Topic Listing for Urologix
Accounting Firm
Agreement Fred Parks
Agreements Arrangements Mitchell Dann Rebecca Weber Stryker Warren
Agreements Arrangements Named Executive Officers
Agreements Other Executive Officers
Agreements Other Named Executive Officers
Allowance Doubtful Accounts
Amendment
Amortization Identifiable Intangible Assets
Amortization Impairment Identifiable Intangible Assets
Amortization Intangible Assets
Amortization Other Intangible Assets
Announces Launch Cooled Thermotherapy Mobile Service
Annual Meeting Special Meetings Bylaw Amendments
Annual Report
Anti-takeover Provisions Articles Incorporation Negative Effect Stock Price
Anti-takeover Provisions Articles Incorporation Possible Negative Effect Stock
Appointment Independent Auditors
Asset Acquisition
Audit Committee Pre-approval Procedures
Audit Committee Report
Audit Fees
Audit-related Fees
Available-for-sale Investments
Avenue North Minneapolis 55447
Backlog
Base Salaries
Base Salary
Basic Diluted Earnings Loss Per Share
Basic Diluted Earnings Per Share
Basic Diluted Loss Earnings Per Share
Basis Presentation
Been Unprofitable Recently
Beneficial Ownership Reporting Compliance
Benefit Plan
Benign Prostatic Hyperplasia
Board Attendance Committee Annual Shareholder Meetings
Board Attendance Meetings
Board Directors
Board Directors Recommends Vote
Board Directors Recommends Vote Nominee Named Below
Board Directors Recommends Vote Nominees Named Below
Board Directors Recommends Vote Nominees Named Below Each
Board Independence
Business Highlights
Business Manufacturing Marketing Sale Medical Devices Involves Risk
Capital Market
Cash Bonus Program
Cash Bonus Program Payouts
Cash Bonuses
Cash Equivalents
Cash Equivalents Grew
Cash Provided Financing Activities
Cash Provided Investing Activities
Cash Provided Operating Activities
Cash Used Investing Activities
Cautionary Regarding Forward-looking Statements
Certain Definitions Relating Change Control
Certain Relationships Related Person Transactions
Certification
Certifications
Changes Disagreements Accountants Accounting Financial Disclosure
Changes Internal Control Over Financial Reporting
Changes Internal Controls Over Financial Reporting
Chief Executive Officer Compensation
Claude Tihon Joins Urologix
Clinical Studies
Closure Fy2006
Code Ethics
Committees Board Directors Committee Independence
Communications Directors
Compensation Committee Report
Compensation Directors
Compensation Philosophy
Competition
Comprehensive Earnings
Comprehensive Earnings Loss
Comprehensive Income Loss
Comprehensive Loss Earnings
Conference Call Information
Consent Independent Registered Public Accounting Firm
Contingencies
Contractual Commitments
Controls Procedures
Cooled Thermotherapy
Cost Goods Sold Asset Impairments Gross Profit
Cost Goods Sold Gross Profit
Cost Method Solicitation
Critical Accounting Policies
Critical Accounting Policies Estimates
Cumulative Effect Adjustment Adoption Sab 108
Current Outlook
Currently Fail Meet Nasdaqs Listing Requirements Common Stock
Deferred Income
Departure Directors Principal Officers Election Appointment
Depend Cooled Thermotherapy Products Revenues
Dependent Adequate Protection Patent Proprietary Rights
Dependent Key Personnel
Description Amendment Annual Report Form 10-k 2008
Description Committees Board Directors
Description Operating Activities
Design 2007 Cash Bonus Program
Design Payouts 2008 Cash Bonus Program
Design Payouts 2009 Cash Bonus Program
Determination Compensation Interim Chief Executive Officer
Determination Compensation Stryker Warren Chief Executive Officer
Determination Severance Compensation
Director Compensation
Director Fees
Director Nominations
Directors Executive Officers Registrant
Directors Serving Continuing Terms
Dividends
Documents Incorporated Reference
Earnings Call Information
Election Directors
Elements In-service Compensation
Elements Post-termination Compensation
Employee Stock Purchase Plan
Employees
Employment Change Control Arrangements
Equity Compensation Plan Information
Equity Granting Process
Estimates
Evaluation Disclosure Controls Procedures
Exact Name Registrant Specified Charter
Except Per Share Data
Executive Compensation
Executive Compensation Philosophy
Executive Leadership Financial Management Experience
Executive Officers
Exhibits
Exhibits Financial Statement Schedules
Exhibits Reports Form 8-k
Experienced Sales Marketing Executive Rejoins Urologix
Explanatory Statement
Faced Intense Competition Rapid Technological Industry Change
Factors Affect Future Results Trading Price Common Stock
Fees Independent Public Accountants
Financial Instruments
Financial Outlook
Financial Results
Financial Statements Exhibits
Fluctuations Future Operating Results Negatively Affect Market Price
Form 10-k
Form 10-q
Forward Looking Statements
Forward-looking Statements
Future Sales Shares Common Stock Negatively Affect Price
General
General Information
Geographic Segment Data
Goodwill Identifiable Intangible Assets
Goodwill Impairment
Goodwill Impairment Reversal Related Deferred Tax Liability
Goodwill Long-lived Assets
Goodwill Other Intangible Assets
Government Regulation
Government Regulation Significant Impact Business
Government Regulation Significant Impact Business Particular Introduction Next
Grants Plan-based Awards 2007
Grants Plan-based Awards 2008
Grants Plan-based Awards 2009
Growth 2009 Revenue
Health Care Regulation
Health Care Regulatory Issues
Held Tuesday 2009
History Unprofitability
Identifiable Intangible Assets Net
Immediate Release
Impact Regulatory Requirements
Income Taxes
Incorporation
Independent Public Accountants
Information Regarding Executive Officers
Information Regarding Nominees
International
Inventories
Inventories Related Allowance Excess Obsolete Inventory
Jerry Cirino Joins Board Bobby Griffin Resigns
Lack Experience Manufacturing Products High Volumes Dependent Limited
Launches Cooled Thermotherapy Mobile Service
Leases
Leases Deferred Rent
Legal Proceedings
Limited Cash Resources Not Additional Financing Available
Limited Experience Manufacturing Some Products Dependent Number Third-party
Limited Inventory Prostatron Control Units Customer Demand Exceeds
Limited Manufacturing Experience Dependent Number Third-party Suppliers Manufacture
Liquidity Capital Resources
Long-term Equity Compensation
Management
Managements Report Internal Control Over Financial Reporting
Manufacturing
Market Registrants Common Equity Related Stockholder Matters Issuer
Minimum Stockholders Equity Non-compliance
Name Exchange Registered
Name Exchange Registered Nasdaq Stock Market Llc
Name Exchange Registered Nasdaq Stock Market Llc Global
Name Person Filing Proxy Statement Other Registrant
Nasdaq Minimum Bid Price Requirement
Nasdaq Stock Market Llc
Net Earnings Loss Per Common Share
Net Earnings Per Common Share
Net Interest Income
Net Loss Per Common Share
Net Sales
New Accounting Pronouncements
Nominee Election Board Directors
Nominees Election Board Directors
Non-gaap Financial Measures
Not Additional Financing Available
Objectives Compensation Programs
Off Balance Sheet Arrangements
Only Attained Profitability Recently
Option Exercises Stock Vested
Option Exercises Year-end Values
Option Grants
Option Grants 2005
Option Grants 2006
Other Accrued Expenses
Other Assets
Other Business
Other Fees
Other Information
Other Intangible Assets Net
Outstanding Equity Awards Year-end
Outstanding Equity Awards Year-end Options
Outstanding Equity Awards Year-end Restricted Stock
Outstanding Equity Awards Year-end Stock
Outstanding Equity Awards Year-end Stock Options
Overview
Part
Part Ii-other Information
Part Other Information
Party Reimbursement Critical Market Acceptance Products
Patents Proprietary Rights
Payable
Performance Graph
Plan
Plan Awards
Please Proxy Indicated Reverse Side Vote
Post-termination Benefits Fred Parks
Post-termination Benefits Fred Parks Elissa Lindsoe Kirsten Doerfert
Post-termination Benefits Other Named Executive Officers
Principal Accountant Fees Services
Principal Financial Officer
Principal Holders Management
Product Liability Insurance
Product Warranty
Products Including Cooled Thermotherapy Mobile Service Not Achieve
Products Including Cooled Thermotherapy Mobile Service Recently Approved
Products Not Achieve Market Acceptance Limit Future Revenue
Products Subject Product Recalls Even After Receiving Fda
Properties
Property Equipment
Provision Income Taxes
Provisions Minnesota Law Governing Documents Other Agreements Deter
Proxy Properly Executed Voted Manner Directed Herein Undersigned
Proxy Solicited Behalf Board Directors
Qualitative Quantitative Disclosure Market Risk
Quantitative Qualitative Disclosures Market Risk
Quorum Voting Requirements
Receives Fda Approval
Recently Issued Accounting Standard
Recently Issued Accounting Standards
Reclassification
Registrants Telephone Number Including Area Code
Registrants Telephone Number Including Area Code 763 475-1400
Reimbursement
Relationship Independent Accountants
Relationship Independent Public Accountants
Relationship Independent Registered Public Accounting Firm
Release Agreement
Report Audit Committee
Report Compensation Committee
Report Independent Registered Public Accounting Firm
Required Pay Damages Exceed Insurance Coverage Product Liability
Research Development
Research Development Costs
Restructuring
Restructuring Liability
Results Operations Financial Condition
Revenue Recognition
Revoking Proxy
Risk Factors
Risks Related Business
Role Compensation Committee Process
Role Management Compensation Process
Sales Marketing
Sales Tax Accrual
Schedule
Seasonality
Securities Exchange
Securities Registered Pursuant Act
Security Ownership Certain Beneficial Owners Management Related Stockholder
See Reverse Voting Instructions
Selling General Administrative
Series Junior Participating Preferred Stock Purchase Rights
Shareholder Proposals 2006 Annual Meeting
Shareholder Proposals 2007 Annual Meeting
Shareholder Proposals 2008 Annual Meeting
Shareholder Proposals 2009 Annual Meeting
Shareholder Proposals 2010 Annual Meeting
Shareholders Urologix Inc
Sidney Emery Joins Board Susan Bartlett Foote Not
Signature
Signatures
Solicitation Proxies
State Other Jurisdiction Incorporation
Stock Options
Stock Price Volatile Shareholders Investment Decline Value
Stock-based Compensation
Submission Matters Vote Security Holders
Submitted Audit Committee Board Directors
Submitted Compensation Committee Board Directors
Summary
Summary Cash Certain Other Compensation
Summary Compensation Table
Table Contents
Tax Fees
Tenth Amendment Lease
Term Expiring Annual Meeting Following 2007
Term Expiring Annual Meeting Following 2008
Term Expiring Annual Meeting Following 2009
Term Expiring Annual Meeting Following 2010
Term Expiring Annual Meeting Following 2011
Terms Expiring Annual Meeting Following 2006
Terms Expiring Annual Meeting Following 2007
Third- Party Reimbursement Critical Market Acceptance Products
Third-party Reimbursement Critical Market Acceptance Products
Trade Accounts Receivable
United States
Unresolved Staff Comments
Update Cooled Thermotherapy Mobile Service
Urologix
Urologix Announces Appointment Ceo Director
Urologix Announces Leadership Changes
Urologix Announces Preliminary Results
Urologix Inc
Urologix Letterhead
Urologix Reports 2006 Results
Urologix Reports 2007 Results
Urologix Reports 2008 Results
Urologix Reports 2009 Results
Urologix Reports Revenue Growth 2009
Urologix Restate Earnings Recognize Non-cash Tax Expense
Valuation Identifiable Intangible Assets Goodwill
Valuation Intangible Assets Goodwill
Valuation Long-lived Intangible Assets Goodwill
Vote Required
Voting
Warranty
Warranty Costs
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour